Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Project Oncology®

The Evolving Landscape of Endometrial Cancer Treatments

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Related
Comments
  • Overview

    It’s important to test all tumors for deficient mismatch repair (MMR) or proficient at first blush to help navigate treatment for patients with advanced or recurrent endometrial cancer. To learn about the evolving landscape of endometrial cancer treatments and data from recent trials, join Dr. Charles Turck as he speaks with Dr. Susana Campos, Vice Chair of the NCCN Committee for Uterine and Cervical Cancer and Assistant Professor of Medicine at the Dana Farber Cancer Institute in Boston.

Recommended
Details
Presenters
Related
Comments
  • Overview

    It’s important to test all tumors for deficient mismatch repair (MMR) or proficient at first blush to help navigate treatment for patients with advanced or recurrent endometrial cancer. To learn about the evolving landscape of endometrial cancer treatments and data from recent trials, join Dr. Charles Turck as he speaks with Dr. Susana Campos, Vice Chair of the NCCN Committee for Uterine and Cervical Cancer and Assistant Professor of Medicine at the Dana Farber Cancer Institute in Boston.

Schedule14 Oct 2024